The National Drug Abuse Treatment Clinical Trials Network (CTN) provides an infrastructure in which the National Institute on Drug Abuse (NIDA), medical and specialty treatment providers, academic centers, researchers, and patients cooperatively develop, validate, refine, and deliver new treatment options for substance use disorders.
The CTN seeks to bridge the gap between research and practice by prioritizing partnerships with an array of community partners to best understand and address the needs of individuals struggling with substance use. This unique partnership enables the conduct of studies evaluating behavioral, pharmacological, and integrated behavioral, neuro-behavioral and pharmacological treatment interventions via rigorous, multi-site clinical trials to determine effectiveness across a broad range of community-based treatment settings and diversified patient populations. Further, it ensures the transfer of research results to physicians, clinicians, providers, and patients in real-world settings.
For more information about the Clinical Trials Network (CTN), click here.
For more information about CTN protocols (historical and current), click here.
For information on publications of the CTN, click here.
